1. Home
  2. TSAT vs AQST Comparison

TSAT vs AQST Comparison

Compare TSAT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telesat Corporation

TSAT

Telesat Corporation

HOLD

Current Price

$44.44

Market Cap

697.5M

Sector

Industrials

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSAT
AQST
Founded
1969
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.5M
504.0M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
TSAT
AQST
Price
$44.44
$3.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$37.00
$9.00
AVG Volume (30 Days)
217.5K
1.8M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
N/A
$10.08
Revenue Next Year
N/A
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$15.90
$2.94
52 Week High
$59.12
$7.55

Technical Indicators

Market Signals
Indicator
TSAT
AQST
Relative Strength Index (RSI) 41.55 43.48
Support Level $43.00 $3.70
Resistance Level $56.88 $4.38
Average True Range (ATR) 4.61 0.15
MACD -1.12 -0.02
Stochastic Oscillator 3.61 23.86

Price Performance

Historical Comparison
TSAT
AQST

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: